Hutch News

Stories tagged 'Diseases'

Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >


Should prostate cancer screening be different for black men?

New study confirms prostate cancer is more common and more deadly in African-Americans

April 23, 2017 | By Linda Carroll for Fred Hutch News Service

Newly published research from Fred Hutch shows black men may be at heightened risk not only of developing prostate cancer but also of having a more aggressive form at a younger age.

View story >


A big-picture look at the world’s worst Ebola epidemic

International team of scientists show how real-time sequencing and data-sharing can help stop the next outbreak

April 12, 2017 | By Mary Engel / Fred Hutch News Service

An international team of scientists analyzed 1,610 Ebola virus genomes for the most comprehensive look to date at the how the 2013-2016 epidemic spread, proliferated and declined across the three West African countries most affected.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 6, 2017

Dr. Marie Bleakley receives innovator award for new leukemia immunotherapies; Dr. Anthony Rongvaux receives grant from Lupus Research Alliance; Drs. Benjamin Greer, Wui-Jin Koh win NCCN award.

View story >


Proteowhatnow? 6 questions with a proteomics expert

How a new technology could help identify the best cancer treatment for an individual patient

April 5, 2017 | by Susan Keown / Fred Hutch News Service

As an oncologist, Dr. Mandy Paulovich ran into an "ethical dilemma" when treating her patients. Since then, she's dedicated her career to proteomics in her quest to solve it.

View story >


Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain

‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors

April 4, 2017 | By Rachel Tompa / Fred Hutch News Service

A major roadblock to adopting T-cell therapy to solid tumors is what’s known as the tumor microenvironment, the local milieu of non-cancerous cells and molecules in and around the tumor. Fred Hutch researcher Dr. Kristin Anderson and her colleagues in Dr. Phil Greenberg's lab are working to overcome those barriers.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.